TKTL1 Antibodies

Santa Cruz Biotechnology delivers a wide array of TKTL1 monoclonal antibodies for research focused on understanding TKTL1 protein function. TKTL1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TKTL1, or transketolase-like 1, functions as a key enzyme in the pentose phosphate pathway, playing an essential role in cellular metabolism and the generation of nucleotides and amino acids. Research has shown TKTL1's involvement in various biological processes, including cell proliferation and survival. TKTL1 has emerged as a significant focus in cancer research and metabolic studies. Investigating TKTL1 expression and activity can reveal its potential as a biomarker and therapeutic target across multiple diseases. Current research continues to uncover new functions and regulatory mechanisms of TKTL1 in cellular processes. Ongoing studies aim to better understand how TKTL1 influences disease progression and treatment outcomes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TKTL1's role in human health and disease.